Makers of the two most common drugs used to treat and prevent flu should add warnings that they may cause psychiatric side effects, federal regulators have recommended.
The report, by staff members of the
Food and Drug Administration, was posted yesterday in advance of an advisory panel meeting scheduled for Tuesday to review use of the antiviral medications Tamiflu, made by
Roche Holding, and Relenza, from
GlaxoSmithKline.
Five Japanese children who took Tamiflu and became delirious died, and there were reports of abnormal behavior among some children using Relenza, mainly in Japan, where the drug is widely used to treat flu, the documents noted.
Source:
http://www.nytimes.com/2007/11/24/bu...ss&oref=slogin accessed today.
The following members say Thank You:
Would you like to comment?
F.D.A. Staff Recommends a Warning on Flu Drugs
